IRVINE, Calif., April 9, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and cancer diagnostics, today announced that Trilochan Sahoo, M.D. FACMG, has recently joined the Company as Director of Cytogenetics. Dr. Sahoo will report to Wes Tyson, M.D., Chief Medical Officer of CombiMatrix.
Help employers find you! Check out all the jobs and post your resume.
